Ricki Lewis, Ph.D., filed a report for the Multiple Sclerosis Discovery Forum on FDA approval for the upcoming clinical trial of MSC-NPs at the Tisch MS Research Center of New York. Lewis quotes multiple outside experts alongside Saud Sadiq, M.D., director of Tisch MS, on the science behind the trial and on the outstanding questions regarding MSC-NPs and MSC-NP therapy still unresolved in current research. The full article may accessed here.
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.